Viewing data from:

ZINC CHLORIDE IN PLASTIC CONTAINER

NDA

ZINC CHLORIDE | N018959 | HOSPIRA INC

1 strength0 unique patents0 unique exclusivities

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

1 trial from ClinicalTrials.gov, 1 completed

Trial	Phase	Status	Sponsor	Enrollment	Dates
Scintigraphic Evaluation of Contractile and Coronary Reserve in Patients With Ischemic Cardiomyopathy NCT04508608	—	Completed	Tomsk National Research Medical Center of the Russian Academy of Sciences	120	2018-09-01 → 2021-09-01

Source: ClinicalTrials.gov. Trials matched by ingredient name.

API Supply Chain2 active DMFs

2 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

CHEMCON GMBHZINC CHLORIDE

DMF 343482021

METROCHEM API PRIVATE LTDZINC CHLORIDE USP

DMF 369642022

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

3 letters from Drugs@FDA

Source: Drugs@FDA application documents.

Products (1)

#001 — EQ 1MG ZINC/ML

RLDAP

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Jun 26, 1986

No patent or exclusivity listings for this strength.